GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.280 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Jim Cramer Gives His Opinion On SoFi, GoodRx And More ↗

June 20, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said "he is a buyer of Anthony Noto," the CEO of SoFi Technologies Inc (NASDAQ: SOFI). They have been...

Via Benzinga

3 Great Candidates to Be the Summer's Hottest Meme Stocks ↗

June 20, 2021

They're beaten down. Short-sellers have piled on. In other words, they're ideal meme stocks.

Via The Motley Fool

The GoodRx Effect: How GoodRx is Changing the Economics of Healthcare

June 15, 2021

From GoodRx, Inc.

Via Business Wire

Move Over, AMC: Here's a Short Squeeze Candidate With as Much Cash and a Brighter Future ↗

June 12, 2021

The metrics for this digital healthcare platform are headed higher for the right reasons.

Via The Motley Fool

Is GoodRx the Prescription for Your Portfolio? ↗

June 11, 2021

You're probably paying too much for your drugs. Fortunately, there's some help on the way.

Via The Motley Fool

Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, And More ↗

May 29, 2021

Some return buyers were among the insiders acquiring shares this last week. A beauty products company and an online dating outfit were among the firms that saw notable insider buying.

Via Talk Markets

Notable Insider Buys Of The Last Week: Bumble, Coty, Peloton Interactive, More ↗

May 29, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near all-time highs. Some return buyers were among the insiders...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 28, 2021 ↗

May 28, 2021

Upgrades For Delek US Holdings Inc (NYSE:DK), Tudor Pickering upgraded the previous rating of Hold to Buy. For the first quarter, Delek US Hldgs had an EPS of $1.69,...

Via Benzinga

Here's the Top Takeaway for Healthcare Investors Right Now ↗

May 27, 2021

There are just three words to remember.

Via The Motley Fool

Topics Cannabis

Notable Insider Buys Of The Past Week: AT&T, GoodRx, Opendoor Technologies, And More ↗

May 23, 2021

A couple of chief executive officers and a president were among the insiders buying shares this past week. A leading telecom that just announced a major deal was among companies that saw notable...

Via Talk Markets

Notable Insider Buys Of The Past Week: AT&T, GoodRx, Opendoor Technologies And More ↗

May 23, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A couple of chief executive officers and a president were...

Via Benzinga

Is Now the Time to Buy This Pharma Industry Disruptor? ↗

May 20, 2021

This consumer healthcare platform went public last fall and is looking to shake up a big part of the healthcare industry.

Via The Motley Fool

Topics Initial Public Offering

Stocks That Hit 52-Week Lows On Friday ↗

May 14, 2021

Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian...

Via Benzinga

GoodRx Holdings, Inc. (GDRX) Q1 2021 Earnings Call Transcript ↗

May 14, 2021

GDRX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

13 Stocks Moving In Thursday's After-Hours Session ↗

May 13, 2021

Gainers DoorDash (NYSE: DASH) shares are trading higher after the company reported better-than-expected Q1 sales results. Bionano Genomics (NASDAQ: BNGO) shares are trading higher...

Via Benzinga

GoodRx Releases First Quarter 2021 Financial Results

May 13, 2021

From GoodRx

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

May 10, 2021

Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....

Via Benzinga

SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles is Investigating GoodRx Holdings, Inc. on Behalf of Shareholders

May 06, 2021

SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles is Investigating GoodRx Holdings, Inc. (GDRX) on Behalf of Shareholders

Via EIN Presswire

Topics Initial Public Offering Lawsuit

GoodRx to Present Virtually at Upcoming Investor Conferences

May 05, 2021

From GoodRx

Via Business Wire

Shareholder Alert: Robbins LLP is Investigating GoodRx Holdings, Inc. (GDRX) on Behalf of Shareholders

May 05, 2021

From Robbins LLP

Via Business Wire

Technology Companies Find Opportunity as Healthcare Goes Digital

May 04, 2021

Via FinancialNewsMedia

GoodRx Announces Streamlined Access to Sanofi Savings Programs

April 27, 2021

From GoodRx

Via Business Wire

GoodRx Expands Manufacturer Solutions Offering with Acquisition of HealthiNation

April 19, 2021

From GoodRx, Inc.

Via Business Wire

GoodRx Announces Date for First Quarter 2021 Earnings Release and Conference Call

April 15, 2021

From GoodRx Holdings Inc.

Via Business Wire

Which Companies Will Be Most Hurt by Amazon's Move Into Healthcare? ↗

April 14, 2021

The conglomerate has moved into prescription drug distribution and is looking at options for telehealth medicine.

Via The Motley Fool

3 Growth Stocks That Could Be Great Long-Term Investments ↗

April 12, 2021

These three growth stocks are down big. The decline in stock price could mean a great buying opportunity for long-term investors.

Via The Motley Fool

These 3 Stocks Are Absurdly Overvalued Right Now ↗

April 09, 2021

The best buy on this list trades over a ridiculous 60 times its future earnings.

Via The Motley Fool

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.